Concerto doses first subject in Phase I trial of ENS-002 for atopic dermatitis
Concerto Biosciences leveraged its screening technology, kChip, for the discovery of ENS-002.
Clinical Trials
GigaGen commences Phase I clinical trial of GIGA-2339 for hepatitis B treatment
MSD reports topline outcomes from Phase III NSCLC trial of pembrolizumab
Emmecell reports positive data from trial of cell therapy for corneal oedema
Johnson & Johnson reports topline outcomes from trial of icotrokinra for psoriasis
Gilead’s Livdelzi shows promise in PBC clinical trial
Alnylam reveals trial outcomes of nucresiran for ATTR amyloidosis treatment
Eli Lilly reports outcomes from Phase III trial of tirzepatide for HFpEF
